Skip to content
voxNeuro, unlocking the brain, logo.

VoxNeuro Announces Significant Milestones as it Embarks on its Mission to Become “The Brain Company”

ORIGINAL ARTICLE – Financial Post, March 30, 2022

TORONTO — VoxNeuro Inc. (“VoxNeuro” or the “Company”), a Software as a Medical Device (SaMD) brain health company that analyzes brain-based biomarkers to assess cognitive function, announced a number of significant developments including (i) receipt of US patent 11278230 entitled “Systems and methods for cognitive health assessment” which provides protection for VoxNeuro’s competitive advantage (specific EEG-based neuropsychological assessments that generate event-related potentials associated with key cognitive functions, and the output of a cognitive health report), (ii) the establishment of a US-based expert clinical study program to assist in expanding VoxNeuro’s product offerings across a range of neurological pathologies, and (iii) the retainer of a seasoned executive, Jason Flowerday, as Chief Executive Officer.

Mr. Flowerday joins VoxNeuro as it prepares to solidify its product development plans and pipeline. Following the launch of its first product in the Spring of 2021, a SaMD general cognitive assessment that healthcare providers leverage in clinical decision-making, VoxNeuro is in the process of formalizing partnerships with channel partners to assist with its roll-out across the United States. In parallel, the Company is working to finalize its initial clinical programs with leading American institutions and medical specialists to develop a series of valuable diagnostic products in the areas of Depression, Concussion, Alzheimer’s, Schizophrenia and Bi-polar disorder. The Company expects that these clinical programs will commence in the second half of 2022.

To continue reading CLICK HERE.

 

Share this article
Facebook
Twitter
LinkedIn
WhatsApp
Email
View All Categories

Featured iF Clients

Whether you are looking for support in product development, validation or just networking, our role is to help make services more visible to you and to reduce the amount of time it takes to activate these supports.

Ready to accelerate your business growth?

Founders Fast Track is 6 week mentorship program that provides your startup with access to industry expertise, resources, networking opportunities, and skills to help you secure investment capital.

Applications are open until April 13, 2025. 

Synapse Life Science Pitch Competition March 26, 2025 from 4:00pm - 8:00pm EDT

Get tickets for the 2025 Synapse Competition!

Innovation Factory’s Synapse Competition is Ontario’s premier life science pitch competition, dedicated to fostering innovation in the life science sector.

Why you should attend:

  • Meet the finalists at the 12th annual Synapse Competition showcase!
  • Discover emerging life science innovations
  • Network with industry leaders and Ontario’s thriving life science ecosystem.

March 26, 2025 | 4:00pm – 8:00pm EDT